Haemonetics Corporation (HAE)

NYSE: HAE · Real-Time Price · USD

102.92

+0.07 (0.07%)

At close: Sep 4, 2026, 4:00 PM EDT

102.53

-0.39 (-0.38%)

After-hours: Sep 4, 2026, 7:46 PM EDT

Haemonetics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 4, 2026	Mar '26 Mar 28, 2026	Mar '25 Mar 29, 2025	Mar '24 Mar 30, 2024	Apr '23 Apr 1, 2023	Apr '22 Apr 2, 2022
Market Capitalization	4,683	2,511	3,175	4,335	4,175	3,263
Market Cap Growth	82.42%	-20.89%	-26.76%	3.83%	27.92%	-42.69%
Enterprise Value	5,632	3,373	4,145	5,011	4,717	3,809
Last Close Price	102.92	54.04	63.19	85.35	82.75	63.85

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 4, 2026	Mar '26 Mar 28, 2026	Mar '25 Mar 29, 2025	Mar '24 Mar 30, 2024	Apr '23 Apr 1, 2023	Apr '22 Apr 2, 2022
PE Ratio	49.99	25.81	18.93	36.87	36.17	75.24
Forward PE	18.80	10.46	13.21	20.49	25.45	23.82
PS Ratio	3.46	1.88	2.33	3.31	3.57	3.29
PB Ratio	5.59	3.15	3.87	4.51	5.10	4.36
P/TBV Ratio	-	-	-	-	54.93	-
P/FCF Ratio	16.08	9.64	22.29	30.18	51.08	43.08
P/OCF Ratio	14.27	8.57	17.47	23.85	15.29	18.95
PEG Ratio	1.74	0.96	1.00	1.39	2.42	1.36

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 4, 2026	Mar '26 Mar 28, 2026	Mar '25 Mar 29, 2025	Mar '24 Mar 30, 2024	Apr '23 Apr 1, 2023	Apr '22 Apr 2, 2022
EV/Sales Ratio	4.17	2.53	3.05	3.83	4.04	3.84
EV/EBITDA Ratio	15.70	9.44	11.65	17.04	18.72	19.87
EV/EBIT Ratio	22.10	13.41	16.78	24.38	28.21	36.22
EV/FCF Ratio	19.34	12.95	29.10	34.89	57.71	50.28

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 4, 2026	Mar '26 Mar 28, 2026	Mar '25 Mar 29, 2025	Mar '24 Mar 30, 2024	Apr '23 Apr 1, 2023	Apr '22 Apr 2, 2022
Debt / Equity Ratio	1.40	1.60	1.56	0.91	1.02	1.12
Debt / EBITDA Ratio	3.18	3.47	3.49	2.87	3.28	4.14
Debt / FCF Ratio	4.03	4.89	9.01	6.08	10.16	11.07
Net Debt / Equity Ratio	1.13	1.29	1.19	0.72	0.67	0.77
Net Debt / EBITDA Ratio	2.65	2.88	2.74	2.36	2.16	3.02
Net Debt / FCF Ratio	3.26	3.95	6.85	4.83	6.67	7.64
Asset Turnover	0.56	0.55	0.59	0.63	0.62	0.54
Inventory Turnover	1.65	1.61	1.71	2.08	1.98	1.50
Quick Ratio	1.67	1.64	0.88	1.29	1.85	0.95
Current Ratio	3.08	2.95	1.62	2.56	3.06	1.71
Return on Equity (ROE)	11.20%	12.03%	18.83%	13.22%	14.72%	5.86%
Return on Assets (ROA)	6.60%	6.49%	6.65%	6.22%	5.51%	3.57%
Return on Invested Capital (ROIC)	10.42%	10.56%	11.33%	10.55%	10.14%	5.40%
Return on Capital Employed (ROCE)	12.10%	11.90%	13.20%	10.80%	9.90%	7.40%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 4, 2026	Mar '26 Mar 28, 2026	Mar '25 Mar 29, 2025	Mar '24 Mar 30, 2024	Apr '23 Apr 1, 2023	Apr '22 Apr 2, 2022
Earnings Yield	2.06%	3.88%	5.28%	2.71%	2.76%	1.33%
FCF Yield	6.22%	10.37%	4.49%	3.31%	1.96%	2.32%
Buyback Yield / Dilution	6.48%	6.65%	1.30%	0.04%	-0.13%	-0.12%

SEC Filings: 10-K · 10-Q